300534.SZ
陇神戎发
SZSE · Healthcare · C 制造业 · CN
CNY 16.70
−8.99%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 843.9M | 887.0M | 1.0B | 1.1B | 799.7M |
| Cost of Revenue | 278.7M | 281.4M | 291.3M | 386.2M | 341.5M |
| Gross Profit | 565.2M | 605.5M | 751.2M | 693.8M | 458.2M |
| Operating Expenses | |||||
| R&D Expense | 27.1M | 27.2M | 28.1M | 30.2M | 27.1M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 53.9M | 55.3M | 60.3M | 52.3M | 48.2M |
| Selling & Marketing Expense | 380.0M | 412.8M | 557.7M | 508.0M | 316.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 475.3M | 509.6M | 657.9M | 599.8M | 398.5M |
| Cost and Expenses | 754.0M | 791.0M | 949.2M | 986.0M | 740.0M |
| Operating Income (EBIT) | 91.5M | 98.5M | 103.8M | 95.2M | 62.3M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 89.6M | 81.1M | 101.8M | 97.0M | 66.1M |
| Income Tax Expense | 17.1M | 15.8M | 51.7M | 13.2M | 17.5M |
| Bottom Line | |||||
| Net Income | 49.4M | 44.0M | 24.5M | 61.6M | 38.8M |
| Earnings from Cont. Ops | 72.5M | 65.4M | 50.1M | 83.9M | 48.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 49.4M | 44.0M | 24.5M | 61.6M | 38.8M |
| Per Share | |||||
| Basic EPS | CN¥0.16 | CN¥0.14 | CN¥0.08 | CN¥0.20 | CN¥0.13 |
| Diluted EPS | CN¥0.16 | CN¥0.14 | CN¥0.08 | CN¥0.20 | CN¥0.13 |
| Revenue Per Share | CN¥2.78 | CN¥2.92 | CN¥3.44 | CN¥3.56 | CN¥2.64 |
| Shares | |||||
| Basic Shares Outstanding | 303.3M | 303.3M | 303.3M | 303.4M | 303.2M |
| Diluted Shares Outstanding | 303.3M | 303.3M | 303.3M | 303.4M | 303.2M |
| Profitability Metrics | |||||
| EBITDA | — | 143.1M | 142.5M | 125.2M | 89.3M |
| D&A | — | 44.6M | 38.8M | 30.0M | 27.0M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026